AI assistant
COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2019
Nov 13, 2019
32163_dirs_2019-11-13_40b0df84-f139-484d-81d8-621038501b58.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2019-11-08
Reporting Person: Fleming Alison B (Chief Technology Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-08 | Common Stock | M | 25000 | $5.73 | Acquired | 98556 | Direct |
| 2019-11-08 | Common Stock | S | 25000 | $19.44 | Disposed | 73556 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-11-08 | Stock Option (Right to Purchase) | $5.73 | M | 25000 | Disposed | 2025-03-19 | Common Stock (25000) | Direct |
Footnotes
F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.10 to $19.71, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The option was fully vested and exercisable as of November 8, 2019.